Samsara BioCapital’s Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third PANA.U Stock Holding History

Samsara BioCapital’s Portfolio PANA.U Stock Details PANA.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-400,000	Closed	-$5.1K	–	52
2020 Q4	$5.1K	Hold	400,000	–	–	0.51%	21
2020 Q3	$4.8M	Buy	+400,000	New	+$4.6M	1.34%	19

Samsara BioCapital's PANA.U Position: Q1 2021 in Review

Samsara BioCapital sold out of Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third (PANA.U) in Q1 2021, closing a stake of 400,000 shares — an estimated $5.1K sold.

Samsara BioCapital first reported a position in PANA.U in Q3 2020 and held it in 2 quarters. The position peaked at $4.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold PANA.U as of Q1 2021.

Samsara BioCapital reported no remaining Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third position as of Q1 2021 after selling out during the quarter.
Samsara BioCapital sold 400,000 Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third shares in Q1 2021, an estimated $5.1K.
Samsara BioCapital first reported a position in Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third in Q3 2020 and held it in 2 quarters.
Samsara BioCapital's Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third position peaked at $4.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third as of Q1 2021.

Based on Samsara BioCapital's 13F filing for Q1 2021, filed 18 May 2021.